Research Biobank From Neuromuscular Biopsy Residues (in the Context of Care)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-26

Study Completion Date

2053-06-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Neuromuscular diseases are rare diseases for which significant progress has been made in the context of diagnosis thanks to advances in molecular techniques, but the intimate mechanisms of lesion formation remain poorly understood. Advances in cellular and molecular biology, the development of a few animal models, such as transgenic mice, which make it possible to mimic human pathology have made it possible to better understand the physiopathology of these diseases. However, they still do so very imperfectly and incompletely, making it even more necessary than ever to study diseased human muscle tissue to find new avenues of research or to confirm results obtained by experimentation.

The purpose of this collection of tissue samples for neuro-muscular purposes is to collect such samples under the best conditions in order to promote basic and translational research on muscle diseases.

This is why the CHU de Bordeaux wishes to keep the remainders of samples taken as part of the treatment to constitute a collection of biological samples and associated data kept according to quality standards and in compliance with the regulations in force.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Innovative Ultrasound Technology in Neuromuscular Disease

NCT02104921

Amyotrophic Lateral Sclerosis Muscular Dystrophy Radiculopathy +4 more

COMPLETED

Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography

NCT03490214

Duchenne Muscular Dystrophy Muscular Dystrophies Muscular Dystrophy, Duchenne

COMPLETED NA

Endomysial Fibrosis, Muscular Inflammatory Response and Calcium Homeostasis Dysfunction in Duchenne Muscular Dystrophy

NCT01823783

Duchenne Muscular Distrophy (DMD)

UNKNOWN NA

Muscle Tissue Bank for Muscular Dystrophy

NCT01950897

Muscular Dystrophies Muscular Dystrophy

COMPLETED

Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies

NCT02109692

Muscular Dystrophies Becker Muscular Dystrophy Duchenne Muscular Dystrophy

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The "COLMYONEU" project is a project to collect leftover frozen neuromuscular biopsy samples from patients taken as part of their health care at the Bordeaux University Hospital for neuromuscular disease.

Its main objective is to store, under the conditions of the CRB standard, residual biological samples from patients with neuromuscular symptoms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuromuscular Diseases Muscle Nerve

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Constitution of biocollection

Collection of remains of neuromuscular biopsy samples (nerve and muscles)

Residual neuromuscular biopsy

Intervention Type OTHER

recovery of residual neuromuscular biopsy (nerve ans muscle)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Residual neuromuscular biopsy

recovery of residual neuromuscular biopsy (nerve ans muscle)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients treated at Bordeaux University Hospital (neurology services, neuropediatrics), rheumatology, medical genetics for suspected neuromuscular disease.
* Men and women are affected, adults and minors.

Eligible Sex

ALL

Accepts Healthy Volunteers

No